Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
· commit biologics
AI Briefing
- Commit Biologics appoints Thomas L. F. Montgomery Andresen, PhD, as CEO to lead complement-powered immune engagers into the clinic.
Advertisement